Pulmonary arterial hypertension treatment: USFDA gives tentative nod to Alembic Pharma Selexipag for Injection Ruchika Sharma13 July 2024 1:30 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the Company has received tentative approval from the US Food & Drug...
USFDA approves Alembic Pharma five products in over a month Ruchika Sharma9 May 2024 1:05 PM ISTMumbai: Alembic Pharmaceuticals Limited announced today that it has received US Food & Drug Administration (USFDA) approvals on five of its...
Lupin secures tentative USFDA nod for Selexipag for Injection Ruchika Sharma2 Nov 2023 4:30 PM ISTThis product will be manufactured at Lupin's Nagpur facility in India.
Zydus Lifesciences gets USFDA nod for Pulmonary Arterial Hypertension drug Selexipag Ruchika Sharma6 May 2022 3:03 PM ISTThe drug will be manufactured at group’s formulation facility at SEZ, Ahmedabad.
FDA Approves IV Formulation of Uptravi for Pulmonary Arterial Hypertension Hina Zahid4 Aug 2021 3:46 PM ISTUSA: The US Food and Drug Administration (FDA) has approved intravenous (IV) formulation of Uptravi (selexipag) injection for the treatment of...
Janssen Pharma Selexipag gets USFDA nod to treat pulmonary arterial hypertension Ruchika Sharma2 Aug 2021 12:15 PM ISTTitusville: The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the U.S. Food and Drug Administration (FDA) has...
FDA approves UPTRAVI to treat pulmonary arterial hypertension savita thakur thakur23 Dec 2015 11:59 AM ISTThe U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic,...
